∞ TICKERS
← Back to Screener

Icon Plc (ICLR)

Price$149.45
Value ScoreC
Growth ScoreC
Momentum ScoreB

Favorite Metrics

Price vs S&P 500 (26W)-27.14%
Price vs S&P 500 (4W)20.06%
VGM Score53.73
Market Capitalization$11.44B
P/E Ratio (Annual)49.90x

All Metrics

P/CF (Annual)11.04x
Book Value / Share (Quarterly)$120.07
P/TBV (Annual)2.34x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)2.15%
Cash Flow / Share (Quarterly)$11.26
Price vs S&P 500 (YTD)-26.14%
Gross Margin (TTM)26.44%
Net Profit Margin (TTM)2.78%
EPS (TTM)$2.80
10-Day Avg Trading Volume1.51M
EPS Excl Extra (TTM)$2.80
Revenue Growth (5Y)24.15%
EPS (Annual)$2.90
ROI (Annual)1.82%
Gross Margin (Annual)26.44%
Net Profit Margin (5Y Avg)5.57%
Cash / Share (Quarterly)$8.45
P/E Basic Excl Extra (TTM)49.90x
Revenue Growth QoQ (YoY)7.29%
EPS Growth (5Y)-14.17%
P/E Normalized (Annual)49.90x
ROA (Last FY)1.41%
Revenue Growth TTM (YoY)-0.37%
EBITD / Share (TTM)$10.48
ROE (5Y Avg)4.84%
Operating Margin (TTM)5.37%
Cash Flow / Share (Annual)$11.26
P/B Ratio1.24x
P/B Ratio (Quarterly)1.51x
Net Income / Employee (Annual)$5,800
EV / Revenue (TTM)1.72x
Net Interest Coverage (TTM)2.33x
ROA (TTM)1.39%
EPS Growth QoQ (YoY)-98.72%
EV / EBITDA (TTM)17.19x
EPS Incl Extra (Annual)$2.90
Current Ratio (Annual)1.10x
Quick Ratio (Quarterly)1.06x
3-Month Avg Trading Volume1.70M
52-Week Price Return10.85%
EV / Free Cash Flow (Annual)16.47x
P/E Incl Extra (TTM)49.90x
Revenue / Employee (TTM)$207,300
Tangible BV / Share (Quarterly)$77.66
P/S Ratio (Annual)1.39x
Asset Turnover (Annual)0.51x
52-Week High$211.00
Operating Margin (5Y Avg)9.23%
EPS Excl Extra (Annual)$2.90
CapEx CAGR (5Y)27.80%
Tangible BV CAGR (5Y)27.21%
26-Week Price Return-19.22%
Quick Ratio (Annual)1.06x
13-Week Price Return35.13%
Total Debt / Equity (Annual)0.37x
Current Ratio (Quarterly)1.10x
Enterprise Value$14.20B
Revenue / Share Growth (5Y)14.77%
Asset Turnover (TTM)0.50x
Book Value / Share Growth (5Y)28.01%
Revenue / Employee (Annual)$207,300
Pretax Margin (Annual)3.06%
Cash / Share (Annual)$8.45
3-Month Return Std Dev61.22%
Gross Margin (5Y Avg)28.08%
Net Income / Employee (TTM)$5,800
EBITDA CAGR (5Y)12.53%
EBITDA Interim CAGR (5Y)-33.13%
ROE (Last FY)2.49%
Net Interest Coverage (Annual)2.33x
EPS Basic Excl Extra (Annual)$2.90
P/FCF (TTM)13.28x
Receivables Turnover (TTM)3.14x
EV / Free Cash Flow (TTM)16.47x
Total Debt / Equity (Quarterly)0.37x
EPS Incl Extra (TTM)$2.80
Receivables Turnover (Annual)3.30x
ROI (TTM)1.79%
P/S Ratio (TTM)1.39x
Pretax Margin (5Y Avg)6.15%
Revenue / Share (Annual)$104.49
Tangible BV / Share (Annual)$77.66
Forward P/E12.25x
Free OCF CAGR (5Y)10.77%
Price vs S&P 500 (52W)-13.51%
P/E Ratio (TTM)49.90x
EPS Growth TTM (YoY)-70.69%
Year-to-Date Return-17.98%
5-Day Price Return8.27%
EPS Normalized (Annual)$2.90
ROA (5Y Avg)2.59%
Net Profit Margin (Annual)2.78%
Month-to-Date Return9.83%
Cash Flow / Share (TTM)$13.22
EBITD / Share (Annual)$10.46
EPS Growth (3Y)-22.02%
Operating Margin (Annual)5.37%
LT Debt / Equity (Annual)0.31x
P/CF (TTM)11.04x
ROI (5Y Avg)3.36%
P/E Excl Extra (TTM)49.90x
LT Debt / Equity (Quarterly)0.31x
EPS Basic Excl Extra (TTM)$2.80
P/TBV (Quarterly)2.34x
P/B Ratio (Annual)1.51x
Pretax Margin (TTM)3.06%
Book Value / Share (Annual)$120.07
Price vs S&P 500 (13W)26.87%
Net Margin Growth (5Y)-25.21%
Beta1.22x
P/FCF (Annual)13.28x
Revenue / Share (TTM)$107.83
ROE (TTM)2.44%
52-Week Low$66.57
vGradeC
gGradeC
mGradeB
vgmGradeC
Show chart for

Earnings Surprise History

Q4 252.52est. 3.18

Analyst Recommendations

Feb 2026
Mar 2026
Apr 2026
May 2026
3.71
3.71
3.75
3.74

About

Icon is a global contract research organization providing clinical trial and drug development services to pharmaceutical, biotechnology, and medical device companies. The company derives the majority of its revenue from clinical research operations, complemented by laboratory and imaging services. Icon is headquartered in Dublin, Ireland.